Johnson Financial Group, Inc. Bristol Myers Squibb CO Transaction History
Johnson Financial Group, Inc.
- $2.64 Billion
- Q3 2025
A detailed history of Johnson Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 16,135 shares of BMY stock, worth $755,279. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,135
Previous 16,466
2.01%
Holding current value
$755,279
Previous $762,000
4.59%
% of portfolio
0.03%
Previous 0.03%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,684Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...